On March 16, 2021 Selvita S.A. [ticker: WSE: SLV] – one of the largest preclinical contract research organizations in Europe, reported that was named the Stock Company of the Year as a result of a competition organized by "Puls Biznesu" – one of the largest business daily in Poland. Selvita also won in two other categories: "The Board Competencies" and "Development Perspectives (Press release, Selvita, MAR 16, 2021, View Source;utm_medium=rss&utm_campaign=selvita-named-the-stock-exchange-company-of-the-year [SID1234576714])."

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

It was the 22nd edition of the competition, which is the oldest and the most prestigious ranking in the Polish capital market. Every year 100 professionals choose the best company. The jury consists of market analysts, investment advisers and managers, institutional investors, and securities house representatives. These experts measure companies in five categories: the management board competencies, success, products and services innovation, investor relations, and development perspectives.

Selvita’s success is spectacular, considering the fact that 2020 was the first full year when the company was listed on the Warsaw Stock Exchange as an independent entity.